These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 18674583

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pandemic influenza vaccines: from the lab to ethical policy making].
    Grotto I, Levine H, Balicer RD.
    Harefuah; 2009 Oct; 148(10):672-6, 735. PubMed ID: 20073393
    [Abstract] [Full Text] [Related]

  • 3. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD.
    Vaccine; 2007 Jun 28; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N, de Radiguès X, World Health Organization H1N1 Vaccine Task Force.
    Vaccine; 2009 Aug 20; 27(38):5184-6. PubMed ID: 19563891
    [Abstract] [Full Text] [Related]

  • 6. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.
    Vaccine; 2008 Mar 25; 26(14):1742-50. PubMed ID: 18336962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant vaccines for influenza virus.
    Tripp RA, Tompkins SM.
    Curr Opin Investig Drugs; 2008 Aug 25; 9(8):836-45. PubMed ID: 18666031
    [Abstract] [Full Text] [Related]

  • 9. [Influenza vaccine: globalization of public health stakes].
    Collin N, Briand S.
    Med Trop (Mars); 2009 Aug 25; 69(4):322. PubMed ID: 19725377
    [Abstract] [Full Text] [Related]

  • 10. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I, Leroux-Roels G.
    Expert Rev Vaccines; 2009 Apr 25; 8(4):401-23. PubMed ID: 19348557
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.
    Katayose M, Hosoya M, Haneda T, Yamaguchi H, Kawasaki Y, Sato M, Wright PF.
    Vaccine; 2011 Feb 17; 29(9):1844-9. PubMed ID: 21195802
    [Abstract] [Full Text] [Related]

  • 13. Pandemic influenza and the global vaccine supply.
    Fedson DS.
    Clin Infect Dis; 2003 Jun 15; 36(12):1552-61. PubMed ID: 12802755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Apr 18; 57(15):393-8. PubMed ID: 18418344
    [Abstract] [Full Text] [Related]

  • 16. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS.
    Biologicals; 2008 Nov 18; 36(6):346-9. PubMed ID: 18715803
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of effective vaccines against pandemic influenza.
    Subbarao K, Murphy BR, Fauci AS.
    Immunity; 2006 Jan 18; 24(1):5-9. PubMed ID: 16413916
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.